Hepion Pharmaceuticals, Inc.
HEPA· OTC
Filed Mar 14, 2019 · 10-K · 73 days after period end · 0001104659-19-014652
derived · Computed from the longer spans the company filed.
| Metric | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2014dderived from reported figures |
|---|---|---|---|
| Net Income | -$2.57M | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Hepion Pharmaceuticals, Inc. · CIK 1583771 · Engraved from SEC EDGAR
ended Dec 31, 2018 · filed Mar 14, 2019 · 73 d after period end